Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

"Given by vein, Day 3~First Inter-Therapy Treatment Bortezomib (Velcade) By vein Days 1 and 4~Second Inter-Therapy Treatment Bortezomib (Velcade) By vein Days 1 and 4~Second Transplant Bortezomib (Velcade) By vein Day -5 and Day -2~Year 1 Maintenance Velcade (bortezomib) By vein Days 1, 8, 15, 22(weekly) Every 28 days~Years 2 \& 3 Maintenance Velcade (bortezomib) By vein Days 1, 8, 15, 22(weekly) Every 56 days"

Given by vein, Days 1, 5, 8, 11

Given by mouth at bedtime, Days 5-8

Given by mouth, once per day Days 5-8

Given by vein, Days 5-8 continuous infusion

Given by vein, days 5-8 continuous infusion

Given by vein days 5-8 continuous infusion

Given by vein days 5-8 continuous infusion